LYMPHOMA RECEIVING CAR-T THERAPY
Clinical trials for LYMPHOMA RECEIVING CAR-T THERAPY explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA RECEIVING CAR-T THERAPY trials appear
Sign up with your email to follow new studies for LYMPHOMA RECEIVING CAR-T THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Off-the-Shelf CAR-T therapy aims to outsmart relapsed blood cancers
Disease control Recruiting nowThis study tests a new CAR-T therapy made from donor cells, so it's ready to use without waiting. It targets two proteins on cancer cells to reduce relapse risk. About 178 adults with hard-to-treat B-cell cancers will receive one infusion after chemotherapy. The main goals are to…
Matched conditions: LYMPHOMA RECEIVING CAR-T THERAPY
Phase: PHASE1, PHASE2 • Sponsor: AvenCell Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
CAR-T Therapy's hidden toll on the brain: new study investigates
Knowledge-focused Recruiting nowThis study looks at how CAR-T cell therapy for lymphoma might affect thinking skills like memory and concentration, as well as brain structure and function. Researchers will follow 120 adult patients over time using tests and brain scans. The goal is to better understand these ch…
Matched conditions: LYMPHOMA RECEIVING CAR-T THERAPY
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC